Duration of anticoagulation after ablation of persistent atrial fibrillation

Duration of anticoagulation therapy following Catheter Ablation of Atrial Fibrillation II; Randomized controlled trial II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004119

Enrollment

100

Registered

2019-07-03

Start date

2015-08-11

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients undergoing catheter ablation for persistent atrial fibrillation are randomly assigned to intervention group and control group. Intervention group receives 1 month of anticoagulation af

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age over 19 years Scheduled catheter ablation for persistent atrial fibrillation CHA2DS2-VASc score 0 or 1

Exclusion criteria

Exclusion criteria: Intracardiac thrombus in preprocedural transesophageal echocardiogram Significant bleeding tendency

Design outcomes

Primary

Measure	Time frame
thromboembolic event	—

Secondary

Measure	Time frame
bleeding event	—

Countries

Korea, Republic of

Contacts

Public ContactYoung Choi

The Catholic University of Korea, Seoul St. Mary's Hospital

coolnite0@gmail.com+82-2-1588-1511

Outcome results